FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

126204001: Liothyronine sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33671018 Liothyronine sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730137019 Liothyronine sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2638031000005119 Liothyroninnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Liothyronine sodium Is a Product containing liothyronine (medicinal product) false Inferred relationship Some
Liothyronine sodium Is a Liothyronine false Inferred relationship Some
Liothyronine sodium Is a Thyroid hormone true Inferred relationship Some
Liothyronine sodium Is a Liothyronine false Inferred relationship Some
Liothyronine sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thyroid hormone (disposition) true Inferred relationship Some
Liothyronine sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Liothyronine true Inferred relationship Some
Liothyronine sodium Is a Hormone false Inferred relationship Some
Liothyronine sodium Is a Drug allergen false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental liothyronine poisoning Causative agent False Liothyronine sodium Inferred relationship Some
Accidental liothyronine overdose (disorder) Causative agent False Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liothyronine sodium 20 microgram powder for solution for injection ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liothyronine sodium preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liothyronine sodium 5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liothyronine sodium 25 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liothyronine sodium 10mcg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Liotrix preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
levothyroxinnatrium + liothyroninnatrium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Accidental liothyronine poisoning Causative agent False Liothyronine sodium Inferred relationship Some
Intentional liothyronine poisoning Causative agent False Liothyronine sodium Inferred relationship Some
forgiftning med liothyronin, uvist med hvilken hensigt Causative agent False Liothyronine sodium Inferred relationship Some
Allergy to liothyronine Causative agent False Liothyronine sodium Inferred relationship Some
Liothyronine overdose Causative agent False Liothyronine sodium Inferred relationship Some 1
Intentional liothyronine overdose Causative agent False Liothyronine sodium Inferred relationship Some 1
overdosis af liothyronin, uvist med hvilken hensigt Causative agent False Liothyronine sodium Inferred relationship Some 1
Poisoning by liothyronine Causative agent False Liothyronine sodium Inferred relationship Some
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
liothyroninnatrium 10 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some
Allergy to liothyronine Causative agent False Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 25 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 25 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 2
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Liothyronine sodium Inferred relationship Some 1
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 5 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 2
Liothyronine sodium 25 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Product containing precisely liothyronine sodium 50 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Liothyronine sodium Inferred relationship Some 1
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 20 microgram powder for solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Liothyronine sodium 20 microgram powder for solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Liothyronine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Liothyronine sodium Inferred relationship Some 2

This concept is not in any reference sets

Back to Start